We've found
184,457
clinical trials
We've found
184,457
clinical trials
Chronic Graft Versus Host Disease Clinical Trial
Updated: 12/31/1969
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Graft Versus Host Disease Clinical Trial
Updated: 12/31/1969
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Chronic Graft Versus Host Disease Clinical Trial
Updated: 12/31/1969
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Subjects With New Onset cGVHD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 12/31/1969
ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Trametinib With or Without Dabrafenib in Treating Patients With BRAF Mutated or Wild Type Metastatic Stage III-IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cannabis Use Disorder Clinical Trial
Updated: 12/31/1969
Effect of Clonazepam on Cannabis Withdrawal and Relapse in Treatment-seeking Patients
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ischemic Cardiomyopathy Clinical Trial
Updated: 12/12/2016
Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury
Status: Enrolling,
Phase
I, II
Updated: 12/12/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Endoscopic Submucosal Dissection Clinical Trial
Updated: 12/31/1969
Multi-center Evaluation of the Clinical Utility of ESD in the Western Population
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Ornithine Transcarbamylase (OTC) Deficiency Clinical Trial
Updated: 12/31/1969
Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset OTC Deficiency
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Breast Neoplasms Clinical Trial
Updated: 3/16/2018
A Registry Study of Breast Microseed Treatment
Status: Enrolling,
Phase
Updated: 3/16/2018
Click here to add this to my saved trials

Anemia Clinical Trial
Updated: 4/30/2018
Transfusion of Biotinylated Red Blood Cells
Status: Enrolling,
Phase
I
Updated: 4/30/2018
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Squamous Non-small Cell Lung Cancer Clinical Trial
Updated: 12/13/2016
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/13/2016
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Lymphoma, Non-Hodgkin Clinical Trial
Updated: 12/31/1969
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Lymphoma, Non-Hodgkin Clinical Trial
Updated: 12/31/1969
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Other Clinical Trial
Updated: 12/31/1969
Reduction of Intrapartum Fever With Intravenous Acetaminophen
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Lung Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Cognitive Disorders Clinical Trial
Updated: 5/2/2017
A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-G3031 in Healthy Subjects
Status: Enrolling,
Phase
I
Updated: 5/2/2017
Click here to add this to my saved trials

Endocrinology, Reproductive Clinical Trial
Updated: 12/31/1969
Investigation of Mechanisms for Transmission of Impaired Glucose Metabolism in Infants Exposed to Diabetes in Utero
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Chemo-radiation Induced Nausea and Vomiting Clinical Trial
Updated: 12/31/1969
Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Unresectable Intrahepatic Cholangiocarcinoma Clinical Trial
Updated: 10/24/2017
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
Status: Enrolling,
Phase
II
Updated: 10/24/2017
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Imaging the Neurochemistry of Drug Addiction With PET
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hepatocellular Cancer Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Other Clinical Trial
Updated: 12/31/1969
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Neurology Clinical Trial
Updated: 12/31/1969
Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
